Medical-tech company Stryker Corp. said Tuesday it has named Timothy Scannell president and chief operating officer, effective Aug. 1.
The company is making the change as David Floyd, group president, orthopaedics, is retiring on June 30, 2019. Scannell started his career with Stryker’s endoscopy business in 1990, serving in sales and marketing roles.
For almost a decade, he has been group president, recently overseeing medsurg and neurotechnology. Stryker shares were not active premarket, but have gained 12% in 2018, while the S&P 500 has gained 4%.
By Ciara Linnane
Source: MarketWatch
CordenPharma announced its largest strategic investment to date, committing to spend ~€900m over the next three years to enhance its peptide technology platform. The planned investment consists of two major expansion initiatives occurring in parallel in the US and Europe, including both existing facilities and new constructions.
DSM-Firmenich has announced the sale of its MEG-3 fish oil business to KD Pharma Group, a contract development and manufacturing organisation that is active in pharmaceutical and nutritional lipids. As part of the transaction, DSM-Firmenich will obtain a minority stake of 29% in KD Pharma’s parent company O³ Holding GmbH.
Veranova, a development and manufacturing of specialist and complex APIs for the pharmaceutica l and biotech sectors, recently announced the appointment of Cécile Maupas as Senior Vice President, Chief Commercial Officer. Cécile will join the executive team and assume responsibility for business development, marketing, project management, commercial operations, and product management.
